U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118215) titled 'A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin' on Aug. 05.
Brief Summary: The purpose of this study is to evaluate the effects of KarXT administration on the drug levels of midazolam, fexofenadine, and digoxin in healthy adult participants.
Study Start Date: Sept. 17
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: KarXT
Specified dose on specified days
DRUG: Midazolam
Specified dose on specified days
DRUG: Fexofenadine
Specified dose on specified days
DRUG: Digoxin
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
...